- Home
- HLP vs XTNT Comparison
HLP vs XTNT Comparison
Compare HLP & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLP
- XTNT
- Stock Information
- Founded
- HLP 2021
- XTNT N/A
- Country
- HLP China
- XTNT United States
- Employees
- HLP N/A
- XTNT N/A
- Industry
- HLP Industrial Machinery/Components
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HLP Industrials
- XTNT Health Care
- Exchange
- HLP Nasdaq
- XTNT Nasdaq
- Market Cap
- HLP 102.1M
- XTNT 89.8M
- IPO Year
- HLP 2023
- XTNT N/A
- Fundamental
- Price
- HLP $1.62
- XTNT N/A
- Analyst Decision
- HLP
- XTNT
- Analyst Count
- HLP 0
- XTNT 0
- Target Price
- HLP N/A
- XTNT N/A
- AVG Volume (30 Days)
- HLP 249.9K
- XTNT 129.9K
- Earning Date
- HLP 09-19-2025
- XTNT 11-11-2025
- Dividend Yield
- HLP N/A
- XTNT N/A
- EPS Growth
- HLP N/A
- XTNT N/A
- EPS
- HLP 0.02
- XTNT N/A
- Revenue
- HLP $16,731,357.00
- XTNT $127,766,000.00
- Revenue This Year
- HLP N/A
- XTNT $13.03
- Revenue Next Year
- HLP N/A
- XTNT N/A
- P/E Ratio
- HLP $70.09
- XTNT N/A
- Revenue Growth
- HLP 19.13
- XTNT 15.16
- 52 Week Low
- HLP $0.61
- XTNT $0.33
- 52 Week High
- HLP $1.82
- XTNT $0.78
- Technical
- Relative Strength Index (RSI)
- HLP 76.04
- XTNT 59.57
- Support Level
- HLP $1.30
- XTNT $0.62
- Resistance Level
- HLP $1.53
- XTNT $0.70
- Average True Range (ATR)
- HLP 0.14
- XTNT 0.04
- MACD
- HLP 0.03
- XTNT 0.00
- Stochastic Oscillator
- HLP 89.83
- XTNT 87.23
About HLP Hongli Group Inc.
Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.